These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34500689)

  • 1. Selected Drug-Likeness Properties of 2-Arylidene-indan-1,3-dione Derivatives-Chemical Compounds with Potential Anti-Cancer Activity.
    Pluskota R; Jaroch K; Kośliński P; Ziomkowska B; Lewińska A; Kruszewski S; Bojko B; Koba M
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indandione and Its Derivatives - Chemical Compounds with High Biological Potential.
    Pluskota R; Koba M
    Mini Rev Med Chem; 2018; 18(15):1321-1330. PubMed ID: 29600759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
    Alam MS; Lee DU
    Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmanicidal and cytotoxic activities and 4D-QSAR of 2-arylidene indan-1,3-diones.
    de Souza APM; Costa MCA; de Aguiar AR; Bressan GC; de Almeida Lima GD; Lima WP; Borsodi MPG; Bergmann BR; Ferreira MMC; Teixeira RR
    Arch Pharm (Weinheim); 2021 Oct; 354(10):e2100081. PubMed ID: 34323311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Indazol-Pyrimidine-Based Derivatives as Selective Anticancer Agents: Design, Synthesis, and In Silico Studies.
    Al-Tuwaijri HM; Al-Abdullah ES; El-Rashedy AA; Ansari SA; Almomen A; Alshibl HM; Haiba ME; Alkahtani HM
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, Anti-Proliferative, Anti-microbial, Anti-Angiogenic Activity and
    Ünver H; Berber B; Demirel R; Koparal AT
    Anticancer Agents Med Chem; 2019; 19(13):1658-1669. PubMed ID: 30887930
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Hammoudi NE; Benguerba Y; Attoui A; Hognon C; Lemaoui T; Sobhi W; Benaicha M; Badawi M; Monari A
    J Biomol Struct Dyn; 2022 Feb; 40(2):886-902. PubMed ID: 32948119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological activity, and four-dimensional quantitative structure-activity analysis of 2-arylidene indan-1,3-dione derivatives tested against
    Andreazza Costa MC; Miguel Castro Ferreira M; Teixeira RR; Martins de Souza AP; Ramos de Aguiar A; R da Silva D; Jonsson CM; Queiroz SCN
    SAR QSAR Environ Res; 2021 Feb; 32(2):133-150. PubMed ID: 33601998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Arylidene-1-indandiones as Pleiotropic Agents with Antioxidant and Inhibitory Enzymes Activities.
    Kouzi O; Pontiki E; Hadjipavlou-Litina D
    Molecules; 2019 Dec; 24(23):. PubMed ID: 31816866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
    Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
    Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
    Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zirconium catalyzed synthesis of 2-arylidene Indan-1,3-diones and evaluation of their inhibitory activity against NS2B-NS3 WNV protease.
    Oliveira AFCDS; de Souza APM; de Oliveira AS; da Silva ML; de Oliveira FM; Santos EG; da Silva ÍEP; Ferreira RS; Villela FS; Martins FT; Leal DHS; Vaz BG; Teixeira RR; de Paula SO
    Eur J Med Chem; 2018 Apr; 149():98-109. PubMed ID: 29499491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structural studies and biological properties of some phosphono-perfluorophenylalanine derivatives formed by S
    Kwiczak-Yiğitbaşı J; Pirat JL; Virieux D; Volle JN; Janiak A; Hoffmann M; Mrzygłód J; Wawrzyniak D; Barciszewski J; Pluskota-Karwatka D
    RSC Adv; 2019 Aug; 9(42):24117-24133. PubMed ID: 35527881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Activity and In Silico ADMET Properties of 2,4,5-Trisubstitutedthiazole Derivatives.
    Al-Jaidi BA; Telfah ST; Bardaweel SK; Deb PK; Borah P; Venugopala KN; Bataineh YA; Al Khames Aga QA
    Curr Drug Metab; 2021; 22(7):532-536. PubMed ID: 33334285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives Using 5,6,8,9-Tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione.
    Mahmoud MAA; Alsharif MA; Mohareb RM
    Anticancer Agents Med Chem; 2021; 21(4):468-486. PubMed ID: 32445457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophilicity and Pharmacokinetic Properties of New Anticancer Dipyridothiazine with 1,2,3-Triazole Substituents.
    Morak-Młodawska B; Jeleń M
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antiproliferative activity and molecular properties predictions of galloyl derivatives.
    da Silva MM; Comin M; Duarte TS; Foglio MA; de Carvalho JE; do Vieira MC; Formagio AS
    Molecules; 2015 Mar; 20(4):5360-73. PubMed ID: 25816079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators.
    Lotfy G; Abdel Aziz YM; Said MM; El Ashry ESH; El Tamany ESH; Abu-Serie MM; Teleb M; Dömling A; Barakat A
    Bioorg Chem; 2021 Dec; 117():105427. PubMed ID: 34794098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterocyclization of 2-Arylidenecyclohexan-1,3-dione: Synthesis of Thiophene, Thiazole, and Isoxazole Derivatives with Potential Antitumor Activities.
    Abdo NYM; Mohareb RM; Al-Darkazali WN
    Anticancer Agents Med Chem; 2020; 20(3):335-345. PubMed ID: 31362693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents.
    Ahmed EA; Mohamed MFA; Omran OA
    RSC Adv; 2022 Sep; 12(39):25204-25216. PubMed ID: 36199335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.